Cargando...
Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
INTRODUCTION: In 2017, neoadjuvant, cisplatin-based chemotherapy followed by radical cystectomy (RC) is considered the gold standard therapy for muscle-invasive bladder based on randomized controlled trials. Across all tumor stages, this approach has been associated with the highest rates of disease...
Gardado en:
| Publicado en: | Indian J Urol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5396398/ https://ncbi.nlm.nih.gov/pubmed/28469298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/iju.IJU_279_16 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|